Micron Pharmaceuticals Limited - Due diligence report
A 360° intelligence report on Micron Pharmaceuticals Limited: trust score, financial health, credit view, compliance, directors, growth and …
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Micron Pharmaceuticals Limited — 360° Intelligence Report
Generated from MCA filings & public recordsMicron Pharmaceuticals Limited is assessed as Moderate with a Trust Score of 70/100. Micron Pharmaceuticals Limited is an active public limited indian non-government company incorporated in 2005, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 22 Nov 2026 from the latest processed filings. Micron Pharmaceuticals Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 0 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Profitable - internal accruals available.
Charges position: 0 open ( 48.0 cr ) · 0 satisfied ( 12.5 cr ).
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2024 - filings overdue.
- Litigation present in 1 court forum(s).
- 1 auditor resignation(s) filed - latest: SWETA GANDHI & CO. on 2021-04-01.
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| PUSHPAK NARESH RANKA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VINOD OTARMAL RANKA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MAHESH KUMAR OTARMAL RANKA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NARESH OTARMAL JAIN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 4 directors on the board.
- MAHESH KUMAR OTARMAL RANKA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
As per FY 2023 annual returnPromoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Veritas Bioventions Pvt Ltd | Associate Company | 74.00% |
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 90 · Distress 70Stakeholder Verdicts
Vendor · Banker · Investor- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
MCA Filings & Events Timeline
Latest 9 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Chimera Biotech Private Limited | U24304DL2019PTC349632 | New Delhi, Delhi, India |
| Team Tony Private Limited | U33201GJ2021PTC120261 | Surendra Nagar, Gujarat, India |
| Opto Electronics Private Limited | U55101KA1976PTC002944 | Banglaore, Karnataka, India |
| Aasabi Machinery Private Limited | U29295MH1994PTC083030 | Dist Thane, Maharashtra, India |
| Franko - India - Drugs Formulations Private Limited | U24299RJ2019PTC064070 | Jaipur, Rajasthan, India |
| Mediline Engineers | U33200DL2021PTC383678 | Delhi, Delhi, India |
| Sidd Life Sciences Private Limited | U33112TN1989PTC017930 | Chennai, Tamil Nadu, India |
| Medi-Bed (India) Private Limited | U33112DL1997PTC088646 | New Delhi, Delhi, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Micron Pharmaceuticals Limited before audits and certifications: compliance score 58/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Micron Pharmaceuticals Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Micron Pharmaceuticals Limited - screening before a deeper diligence.
Vendor verdict: Review suggested. Trust score 70/100, distress signals and MSME payment-delay disclosures - know whether Micron Pharmaceuticals Limited pays its suppliers before you extend credit terms.
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Micron Pharmaceuticals Limited - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Micron Pharmaceuticals Limited an active company?
Micron Pharmaceuticals Limited has MCA status “Active” with a compliance score of 58/100 (Moderate).
Is Micron Pharmaceuticals Limited financially healthy?
Micron Pharmaceuticals Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.
Should I do business with Micron Pharmaceuticals Limited?
Its overall Trust Score is 70/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Micron Pharmaceuticals Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.
Does Micron Pharmaceuticals Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Micron Pharmaceuticals Limited up to date with its ROC filings?
Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 58/100 (Moderate).
Is it risky to lend to Micron Pharmaceuticals Limited?
Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.